Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Krystal Biotech, Inc. (KRYS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/07/2023 8-K Quarterly results
Docs: "Krystal Biotech Announces Second Quarter 2023 Financial Results and Operational Highlights"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/26/2023 8-K Quarterly results
07/18/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 ROSSI DINO A (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Granted 6,800 options to buy @ $117.4, valued at $798.3k
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Granted 6,800 options to buy @ $117.4, valued at $798.3k
07/03/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Granted 6,800 options to buy @ $117.4, valued at $798.3k
06/09/2023 4 JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Sold 4,604 shares @ $127.9578, valued at $589.1k
Sold 1,073 shares @ $129.0218, valued at $138.4k
Sold 5,388 shares @ $128.7335, valued at $693.6k
Sold 5,000 shares @ $127.958, valued at $639.8k
Sold 10,000 shares @ $127.9584, valued at $1.3M
Sold 5,000 shares @ $127.8612, valued at $639.3k
Sold 3,935 shares @ $129.2943, valued at $508.8k
Sold 5,000 shares @ $128.8375, valued at $644.2k
Sold 10,000 shares @ $128.5262, valued at $1.3M
06/09/2023 4 ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Sold 5,261 shares @ $128.1045, valued at $674k
Sold 6,906 shares @ $128.9441, valued at $890.5k
Sold 333 shares @ $129.6972, valued at $43.2k
Exercised 12,500 options to buy @ $63.55, valued at $794.4k
06/09/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/02/2023 4 Krishnan Suma (President, R&D) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Sold 20,143 shares @ $115.9757, valued at $2.3M
Sold 4,557 shares @ $116.8624, valued at $532.5k
Sold 300 shares @ $117.5733, valued at $35.3k
Sold 18,884 shares @ $115.995, valued at $2.2M
Sold 5,716 shares @ $116.9498, valued at $668.5k
Sold 400 shares @ $117.605, valued at $47k
06/02/2023 4 Krishnan Krish S (President and CEO) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Sold 18,884 shares @ $115.995, valued at $2.2M
Sold 5,716 shares @ $116.9498, valued at $668.5k
Sold 400 shares @ $117.605, valued at $47k
Sold 20,143 shares @ $115.9757, valued at $2.3M
Sold 4,557 shares @ $116.8624, valued at $532.5k
Sold 300 shares @ $117.5733, valued at $35.3k
05/31/2023 144 Form 144 - Report of proposed sale of securities:
05/31/2023 144 Form 144 - Report of proposed sale of securities:
05/23/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/23/2023 4 Romano Kathryn (Chief Accounting Officer) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Sold 12,500 shares @ $95.05, valued at $1.2M
Sold 12,500 shares @ $95.0449, valued at $1.2M
Sold 3,428 shares @ $95.0808, valued at $325.9k
Sold 2,521 shares @ $105.8036, valued at $266.7k
Sold 2,570 shares @ $106.8087, valued at $274.5k
Sold 1,300 shares @ $107.8777, valued at $140.2k
Sold 2,955 shares @ $109.1719, valued at $322.6k
Sold 3,154 shares @ $109.9933, valued at $346.9k
Sold 12,500 shares @ $110, valued at $1.4M
Exercised 12,500 options to buy @ $52.26, valued at $653.3k
Exercised 12,500 options to buy @ $52.26, valued at $653.3k
05/23/2023 4 JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Sold 50,000 shares @ $95.0237, valued at $4.8M
05/19/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEKTM for the Treatment of Dystrophic Epidermolysis Bullosa",
"Updated Risk Factors"
05/19/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 144 Form 144 - Report of proposed sale of securities:
05/11/2023 4 JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.
Txns: Sold 17,100 shares @ $90.7356, valued at $1.6M
05/11/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "PA BACKGROUND STUDY DESIGN AND METHODS RESULTS DISCUSSION CONCLUSION ACKNOWLEDGEMENTS"
05/10/2023 SC 13G/A FMR LLC reports a 10.1% stake in KRYSTAL BIOTECH INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy